Short Interest in Tema Oncology ETF (NASDAQ:CANC) Expands By 13.8%

Posted by Amy Steele on Jan 19th, 2025

Tema Oncology ETF (NASDAQ:CANC – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 7,400 shares, a growth of 13.8% from the December 15th total of 6,500 shares. Based on an average daily volume of 11,800 shares, the days-to-cover ratio is currently 0.6 days.

Tema Oncology ETF Price Performance

Shares of Tema Oncology ETF stock traded down $0.03 during trading hours on Friday, hitting $24.46. 27,892 shares of the company’s stock traded hands, compared to its average volume of 50,936. The company has a fifty day simple moving average of $25.87 and a 200-day simple moving average of $27.64. The stock has a market capitalization of $57.48 million, a price-to-earnings ratio of 26.86 and a beta of 1.11. Tema Oncology ETF has a 12-month low of $23.97 and a 12-month high of $30.11.

Tema Oncology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were given a $0.7283 dividend. The ex-dividend date was Wednesday, December 11th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Tema Oncology ETF stock. Thrivent Financial for Lutherans purchased a new position in shares of Tema Oncology ETF (NASDAQ:CANC – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 319,376 shares of the company’s stock, valued at approximately $8,616,000. Thrivent Financial for Lutherans owned 19.01% of Tema Oncology ETF as of its most recent filing with the SEC.

Tema Oncology ETF Company Profile

(Get Free Report)

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.